Oxford Cannabinoid Technologies Holdings plc (LSE: OCTP), the pharmaceutical company developing prescription cannabinoid medicines, is pleased to announce that dosing of
Australian-based, international health and wellness Co adds UK CBD brand Savage Cabbage to complement medicinal cannabis brand Lumir, and operations
A new report from a leading UK cannabis advisory company has highlighted how a failure to capture data related to
The fifth anniversary of Medical Cannabis Awareness Week (#MCAW) is set for 1 – 7 November 2023. Started by PLEA
Alternaleaf, the clinic that’s helped hundreds of thousands of Australians access medical cannabis, today is launching in the UK. The
[London, 26/09/2023] – Prohibition Partners, a leading cannabis industry business media & data business, is pleased to announce a significant
CB21 Pharma, a leading Czech-based pharmaceutical company specializing in producing cannabinoid ingredients and medical devices, has successfully extended its EU
Lyphe Group (“Lyphe”), one of the UK’s leading medical cannabis companies, is pleased to announce an innovative partnership set to
Employers are currently at risk of breaching the Equality Act over their approach to prescription cannabis patients, according to a
Mamedica® – the UK’s fastest-growing medical cannabis clinic, has partnered with Cantourage UK to launch the first of its own-branded products
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.